Name Ralph Snyderman | Role University Professor | |
 | ||
Education | ||
Ralph snyderman md donate your data
Ralph Snyderman is Chancellor Emeritus at Duke University, James B. Duke Professor of Medicine, and director of the Duke Center for Research on Personalized Health Care. He served as Chancellor for Health Affairs and Dean of the School of Medicine from 1989 to July 2004. During this period, he oversaw the development of the Duke University Health System and served as its first President and Chief Executive Officer. Duke University Hospital went from being nationally ranked in 3 specialities and 8th overall in 1991 up to 10 specialties and 6th overall in 2004. Snyderman has played a role in the conception and development of Personalized Health Care, an evolving model of national health care delivery. He has articulated the need to move the current focus of health care from the treatment of disease-events to personalized, predictive, preventative, and participatory care that is focused on the patient. Ralph Snyderman was the recipient of the 2012 David E. Rogers Award from the Association of American Medical Colleges who recognized him as "The Father of Personalized Medicine." He is a member of the National Academy of Medicine.
Contents
- Ralph snyderman md donate your data
- Margaret a hamburg m d fda commissioner ralph snyderman m d pmwc intl
- Early years
- Honors and awards
- References
Margaret a hamburg m d fda commissioner ralph snyderman m d pmwc intl
Early years
A graduate of Washington College in Chestertown, Maryland, Snyderman received his MD in 1965 from SUNY Downstate Medical Center. He served his internship and residency in medicine at Duke, and later worked as a Public Health Officer doing research in immunology at the NIH.
Snyderman accepted his first faculty appointment at Duke in 1972 and by 1984, he was the Frederic M. Hanes Professor of Medicine and Immunology. He is a well-cited researcher in the field of inflammation and has won many awards for his seminal work on leukocyte chemotaxis. Snyderman discovered C5a, a major chemotactic factor responsible for white blood cell accumulation and vascular permiability at sites of inflammation. He also discovered chemotactic lymphokines, anticipating the field of chemokine research. Snyderman has contributed to almost 400 scientific manuscripts.
Honors and awards
